|
Volumn 56, Issue 1-2, 2001, Pages 45-50
|
Lipoprotein-associated PLA2 inhibition - A novel, non-lipid lowering strategy for atherosclerosis therapy
|
Author keywords
Atherosclerosis therapy; Enzyme inhibitors; Lp PLA2; Phospholipase A2
|
Indexed keywords
AZETIDINONE DERIVATIVE;
LOW DENSITY LIPOPROTEIN;
PHOSPHOLIPASE A2;
PYRIMIDINONE DERIVATIVE;
SB 222657;
SB 244323;
UNCLASSIFIED DRUG;
ENZYME INHIBITOR;
LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A(2);
LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2);
PHOSPHOLIPASE A;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
CHRONIC INFLAMMATION;
CONFERENCE PAPER;
DRUG DESIGN;
DRUG SCREENING;
DRUG SYNTHESIS;
ENZYME INHIBITION;
FOAM CELL;
HYPERCHOLESTEROLEMIA;
LIPID OXIDATION;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
ARTERIOSCLEROSIS;
ARTICLE;
DRUG ANTAGONISM;
HUMAN;
ARTERIOSCLEROSIS;
ENZYME INHIBITORS;
HUMANS;
PHOSPHOLIPASES A;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0035273244
PISSN: 0014827X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-827X(01)01011-4 Document Type: Conference Paper |
Times cited : (46)
|
References (13)
|